Literature DB >> 7443534

Mechanism of RNA-protein interactions in tobacco mosaic virus: analysis of the pH stability of virus protein complexes with synthetic polynucleotides.

R K Ledneva, T P Lanina, G V Terganova, A A Bogdanov.   

Abstract

TMV-like RNP complexes were reconstituted from TMV protein and synthetic polynucleotides. Analysis of the pH stability of RNP with polynucleotides containing U, G, or their analogues reveals a correlation between the stability of their structure and the pK values of the bases, and indicates that the -NH-CO-groups of U and G are involved in hydrogen bonding with protein. It is suggested that TMV protein has two U- and one G-specific binding sites which, according to the phase position of the protein subunits relative to the origin of TMV assembly (D. Zimmern (1977), Cell 11, 463) are likely to be organized as UGU. The binding of the A and C residues of RNA with TMV protein is nonspecific. TMV protein groups with pK 6.3, 7.5 and 9.7 were found to be essential in the protein-protein interactions in RNP. A group of the protein with pK 8.2 is also involved in RNP stabilization. Both protein-protein interactions and interactions of protein with RNA phosphate groups were shown to be mediated by a conformational change in the protein induced by base binding. The effect of bases on both types of interactions changes in the order G approximately equal to much greater than A, and incorporation of C in RNP proceeds in a compulsory way at the expense of interaction of the neighbouring nucleotide residues in polynucleotides with protein. The data obtained are used to discuss the principles of the cooperativity of the interactions between TMV components and the mechanism of initiation and elongation in TMV self-assembly.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7443534      PMCID: PMC324284          DOI: 10.1093/nar/8.21.5129

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  16 in total

1.  Cation binding by tobacco mosaic virus.

Authors:  A C Durham; D A Hendry
Journal:  Virology       Date:  1977-04       Impact factor: 3.616

2.  RECONSTITUTION OF TOBACCO MOSAIC VIRUS. IV. INHIBITION BY ENZYMES AND OTHER PROTEINS, AND USE OF POLYNUCLEOTIDES.

Authors:  H FRAENKEL-CONRAT; B SINGER
Journal:  Virology       Date:  1964-07       Impact factor: 3.616

3.  Degradation of tobacco mosaic virus with acetic acid.

Authors:  H FRAENKEL-CONRAT
Journal:  Virology       Date:  1957-08       Impact factor: 3.616

4.  A prediction of the structure of tobacco-mosaic-virus protein.

Authors:  A C Durham
Journal:  Eur J Biochem       Date:  1975-05-06

5.  The characterization of intermediates formed during the disassembly of tobacco mosaic virus at alkaline pH.

Authors:  R N Perham; T M Wilson
Journal:  Virology       Date:  1978-02       Impact factor: 3.616

6.  A study of the interaction of TMV protein with single- and double-stranded polynucleotides.

Authors:  T P Lanina; G V Terganova; R K Ledneva; A A Bogdanov
Journal:  FEBS Lett       Date:  1976-08-15       Impact factor: 4.124

7.  The nucleotide sequence at the origin for assembly on tobacco mosaic virus RNA.

Authors:  D Zimmern
Journal:  Cell       Date:  1977-07       Impact factor: 41.582

8.  The enzymatic synthesis of poly 4-thiouridylic acid by polynucleotide phosphorylase from Escherichia coli.

Authors:  J Simuth; K H Scheit; E M Gottschalk
Journal:  Biochim Biophys Acta       Date:  1970-04-15

9.  Interaction of tobacco mosaic virus protein with synthetic polynucleotides containing a fluorescent label: optical properties of poly(A,epsilonA) and poly(C,epsilonC) copolymers and energy migration from the tryptophan to 1,N6-ethenoadenine or 3,N4-ethenocytosine residues in RNP.

Authors:  R K Ledneva; A P Razjivin; A A Kost; A A Bogdanov
Journal:  Nucleic Acids Res       Date:  1978-11       Impact factor: 16.971

10.  Binding of oligonucleotides to the disk of tobacco-mosaic-virus protein.

Authors:  J Graham; P J Butler
Journal:  Eur J Biochem       Date:  1979-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.